These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3123184)

  • 1. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.
    Groop L; Groop PH; Stenman S; Saloranta C; Tötterman KJ; Fyhrquist F; Melander A
    Diabetes Care; 1987; 10(6):671-8. PubMed ID: 3123184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
    Lev JD; Zeidler A; Kumar D
    Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide.
    Jaber LA; Wenzloff NJ; Komanicky P; Antal EJ
    J Clin Pharmacol; 1990 Feb; 30(2):181-8. PubMed ID: 2107214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
    Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F
    Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
    Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
    Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.
    Birkeland KI; Furuseth K; Melander A; Mowinckel P; Vaaler S
    Diabetes Care; 1994 Jan; 17(1):45-9. PubMed ID: 8112188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and risks with glyburide and glipizide in elderly NIDDM patients.
    Brodows RG
    Diabetes Care; 1992 Jan; 15(1):75-80. PubMed ID: 1737544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
    Simpson HC; Sturley R; Stirling CA; Reckless JP
    Diabet Med; 1990 Feb; 7(2):143-7. PubMed ID: 2137755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.
    Kitabchi AE; Kaminska E; Fisher JN; Sherman A; Pitts K; Bush A; Bryer-Ash M
    Am J Med Sci; 2000 Mar; 319(3):143-8. PubMed ID: 10746824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus.
    Kilo C
    Clin Ther; 1988; 10(3):294-302. PubMed ID: 3152586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
    Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and sulphonylurea in the therapy of type 2 diabetes.
    Sotaniemi EA; Vierimaa E; Huupponen R; Karvonen I; Vuoti MJ; Rytömaa K
    Diabetes Res Clin Pract; 1990 Mar; 8(3):243-51. PubMed ID: 2111239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
    JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term insulin therapy upon therapeutic response to glipizide.
    Schwartz SL; Fischer JS; Kipnes MS; Boyle M
    Am J Med; 1987 Sep; 83(3A):22-30. PubMed ID: 3307403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of two sulfonylureas. Does it make sense.
    Salo S; Groop L
    Diabetes Care; 1988 Oct; 11(9):751-3. PubMed ID: 3147175
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.
    Berelowitz M; Fischette C; Cefalu W; Schade DS; Sutfin T; Kourides IA
    Diabetes Care; 1994 Dec; 17(12):1460-4. PubMed ID: 7882817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic sulfonylurea therapy augments basal and meal-stimulated insulin secretion while attenuating insulin responses to sulfonylurea per se.
    McIntyre HD; Ma A; Bird DM; Patterson CA; Cameron DP
    Diabetes Care; 1992 Nov; 15(11):1534-40. PubMed ID: 1468283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.
    Rosenstock J; Meisel A; Raskin P
    Am J Med; 1987 Sep; 83(3A):10-5. PubMed ID: 3307402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyburide versus glipizide in the treatment of patients with non-insulin-dependent diabetes mellitus.
    Kilo C; Meenan A; Bloomgarden Z
    Clin Ther; 1992; 14(6):801-12. PubMed ID: 1286487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes control in the elderly: a randomized, comparative study of glyburide versus glipizide in non-insulin-dependent diabetes mellitus.
    Rosenstock J; Corrao PJ; Goldberg RB; Kilo C
    Clin Ther; 1993; 15(6):1031-40. PubMed ID: 8111800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.